Atherosclerosis in male patients with ankylosing spondylitis: The relation with methylenetetrahydrofolate reductase (C677T) gene polymorphism and plasma homocysteine levels

Rheumatology International

Volumn 33, Issue 6, 2013, Pages 1519-1524

  Geçene, Muharrem ^a   Tuncay, Figen ^b   Borman, Pinar ^a   Yücel, Dogan ^a   Senes, Mehmet ^a   Yilmaz, Behice Kaniye ^a  

^a Department of Physical Medicine and Rehabilitation ^*

^b Ankara Numune Research and Education Hospital   (Turkey)

Author keywords

Ankylosing spondylitis; Atherosclerosis; Doppler ultrasonography; Homocysteine levels; Intima media thickness; MTHFR C677T gene polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADALIMUMAB; CYANOCOBALAMIN; ETANERCEPT; FOLIC ACID; HOMOCYSTEINE; LIPID; SALAZOSULFAPYRIDINE;

ADULT; AMINO ACID BLOOD LEVEL; ANKYLOSING SPONDYLITIS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ECHOGRAPHY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; INTIMA; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SPINE MOBILITY;

ADULT; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; GENOTYPE; HOMOCYSTEINE; HUMANS; LOGISTIC MODELS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 84878734679     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2552-8     Document Type: Article

References (25)

1. Choe JY, Lee MY, Rheem I, Rhee MY, Park SH, Kim SK (2008) No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls. Joint Bone Spine 75:548-553
2. Palazzi C, D'Angelo S, Lubrano E, Olivieri I (2008) Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol 26:131-134
3. Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, Lusson JR, Soubrier M (2008) Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology 47:1203-1207
4. Heeneman S, Daemen MJ (2007) Cardiovascular risks in spondyloarthritis. Curr Opin Rheumatol 19:358-362
5. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167-2172
6. Wei JC, Jan MS, Yu CT, Huang YC, Yang CC, Tsou HK, Lee HS, Chou CT, Tsay G, Chou MC (2007) Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol 739-42
7. Başkan BM, Sivas F, Aktekin LA, Doǧan YP, Ozoran K, Bodur H (2009) Serum homocysteine level in patients with ankylosing spondylitis. Rheumatol Int 29:1435-1439
8. Khandanpour N, Willis G, Meyer FJ, Armon MP, Loke YK, Wright AJ, Finglas PM, Jennings BA (2009) Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: a case-control study and meta-analysis. J Vasc Surg 49:711-718
9. Cho SE, Hong KS, Shin GJ, Chung WS (2006) The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea. Clin Chem Lab Med 44:1070-1075
10. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthr Rheum 27:361-368
11. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
12. Machado P, Landewe R, Lie E et al (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70:47-53
13. Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 21:1694-1698
14. Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Ishimura E, Inui K, Yutani Y, Miki T, Shoji T, Nishizawa Y (2002) Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthr Rheum 46:1489-1497
15. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146:483-494
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22
17. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC (2004) Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 109:1089-1094
18. Erre GL, Sanna P, Zinellu A, Ponchietti A, Fenu P, Sotgia S, Carru C, Ganau A, Passiu G (2011) Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin Rheumatol 30:21-27
19. Peters MJ, van Eijk IC, Smulders YM, Serne E, Dijkmans BA, van der Horst-Bruinsma IE, Nurmohamed MT (2010) Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 37:161-166
20. Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G (2007) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26:710-714
21. Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A (2009) Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. Clin Exp Rheumatol 27:499-502
22. Tasbas O, Borman P, Gürhan Karabulut H, Tükün A, YorgancIoǧlu R (2011) The frequency of A1298C and C677T polymorphisms of the methylenetetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol J 5:30-35
23. van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB (2001) The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum 44:2525-2530
24. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, Lopez-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI (2008) Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28:1223-1228
25. Ghilardi G (1994) Carotid stenotic-obliterative lesions. Distribution in 16,379 subjects 45-75 years of age. Minerva Cardioangiol 42:345-350